Annovis Bio (FRA:07X) Institutional Ownership: 5.88% (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:07X Annovis Bio Inc FRA:07X
38 GF Score
Price €1.46
! 1 Warning Sign
View Full Analysis

What is Annovis Bio Institutional Ownership?

Annovis Bio FRA:07X -4.71% 38 Institutional Ownership is 5.88% as of Jul. 28, 2026. GuruFocus rates FRA:07X with a GF Score™ of 38/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Annovis Bio's institutional ownership is 5.88%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Annovis Bio's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Annovis Bio's Float Percentage Of Total Shares Outstanding is 91.11%.

Annovis Bio Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Annovis Bio's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annovis Bio Institutional Ownership Chart

Annovis Bio Historical Data

The historical data trend for Annovis Bio can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 6.87 5.31 5.42 5.63 5.98 6.00 6.25 5.15 5.70 5.88
FRA:07X
38GF Score
Annovis Bio Inc FRA:07X
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annovis Bio Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 5.88% mean?
Annovis Bio (FRA:07X) has a Institutional Ownership of 5.88% as of Jul. 28, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Annovis Bio and its competitors.
Is Annovis Bio's Institutional Ownership too high?
Annovis Bio's current Institutional Ownership is 5.88%. Overall, Annovis Bio has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Annovis Bio's Institutional Ownership compare to IBIO and ENLV?
Annovis Bio's Institutional Ownership of 5.88% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Annovis Bio and its competitors. Annovis Bio's current Institutional Ownership is 5.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annovis Bio stock overvalued right now?
Annovis Bio (FRA:07X) has a current Institutional Ownership of 5.88%. The current Institutional Ownership is 5.88%. Annovis Bio's overall GF Score™ is 38/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Annovis Bio (FRA:07X), the current Institutional Ownership is 5.88% as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annovis Bio Business Description

Other Exchanges ANVS:USA
Address 101 Lindenwood Drive, Suite 225, Malvern, PA, USA, 19355
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
38GF Score

Get the complete analysis for FRA:07X

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.46
Price